FDA 483 - Lonza Tampa LLC - October 01, 2021

Xcelience LLC, a drug manufacturer in Tampa, FL, was cited for significant deficiencies in its quality control unit and master production and control records. The inspection revealed failures to thoroughly investigate deviations and cleaning issues, leading to the release of non-conforming product. Additionally, master records lacked complete instructions for manufacturing and sampling of finished drug products.